Brain damage following a stroke, brain tumor or accident often results in walking impairments. The huge variation in problems and treatment options makes this a very difficult problem to treat. Researchers and doctors working in the Loop Expertise Centrum (Centre of Excellence for Walking) run by Sint Maartenskliniek and Radboud university medical center have developed a method for treating these walking impairments. Their article will be published in the 26 February edition of JAMA Neurology.Treating walking impairments after brain damage is complex. There is a huge variation in walking abnormalities and patients find all kinds of ways to compensate for their abnormal gait. In addition, there is a variety of treatment options: physiotherapy, medication, splints, or surgical procedures. Very little scientific research has been carried out into choosing the correct treatment. There are no solid guidelines, so there is a large variation in clinical practice.
Junior rehabilitation doctor and researcher Jorik Nonnekes and colleagues from Radboud university medical center and Sint Maartenskliniek have now developed an algorithm for treating walking impairments resulting from brain damage. They have distinguished three main categories of causes: a deviant foot angle, calf muscle weakness and over-active thigh muscles. Based on research literature and their own experience in treating walking impairments, the doctors and researchers have defined an optimum approach to treating these impairments. Surprisingly, surgical interventions play a prominent role.
Jorik Nonnekes: “It’s difficult to find the correct treatment for patients with walking impairments resulting from brain damage. Long periods of physiotherapy and orthopedic shoes are often the first preferred option, with surgical interventions, such as lengthening a tendon or fixating a joint in the foot, coming much later. We have learned from experience that it can be better to look at the surgical options sooner rather than later.”
This was the case for Lenny van Eck (37). After a stroke in 2012, she continued to have problems walking. She was initially prescribed physiotherapy and orthopedic shoes. But last year, she had an operation to correct the angle of her foot: “I’m so pleased I went ahead with this. My toes used to point downwards, but now they’re straight. After five years of special shoes, I can now wear my own shoes again. Walking did was painful before the operation, but not anymore. I can walk much further now too. I should have done this ages ago.”
Food for thought
Many treatment centers do not consider surgical options because they lack the facilities. So over the past few years, the Loop Expertise Centrum of Radboud university medical center and Sint Maartenskliniek have been encouraging orthopedic surgeons and rehabilitation doctors to work together to treat walking impairments. According to the researchers, a systematic approach to walking problems is the first step towards developing solid guidelines. Follow-up research is needed to compare the various effects of the different treatments. Nonnekes: “We have already received enthusiastic reactions from the reviewers, indicating that our publication gives food for thought and a reason to evaluate the current approach to this problem in the United States.”
Related news items
Lowering cholesterol is not enough to reduce hyperactivity of the immune system14 June 2019
In Cell Metabolism, Siroon Bekkering, theme Vascular damage, and colleagues, provides a novel potential explanation for the residual cardiovascular risk, related to persistent activation of the immune system in patients with hypercholesterolemia who are treated with statins.read more
A personal touch of Johan van der Vlag13 June 2019
In order to promote interaction amongst colleagues within RIMLS, we have a ‘personal touch’ series setting employees in the spotlight. A light-hearted manner to learn about the colleagues you know and those you don’t. This week: Johan van der Vlag.read more
Peter van der Kraan new theme leader Inflammatory diseases13 June 2019
It is our pleasure to introduce Peter van der Kraan from the Dept. of Rheumatology, as the new leader of our theme Inflammatory diseases. As such he will be the successor of Irma Joosten who has done an outstanding job in the last years as theme leader, for which we thank her wholeheartedly.read more
Intake of a reduced dose of pazopanib with food the effect on pharmacokinetics, patient safety and preference13 June 2019
In Clinical Pharmacology & Therapeutics Floor Lubberman and colleagues showed that the intake of 600mg pazopanib with food resulted in a bioequivalent exposure and was preferred over a standard pazopanib dose without food.read more